US Patent 10035850 Methods for treating neovascular age-related macular degeneration
Patent 10035850 was granted and assigned to Novartis on July, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10035850 Methods for treating neovascular age-related macular degeneration
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
